Edgewise Therapeutics, Inc. Common Stock (EWTX) is a publicly traded Healthcare sector company. As of July 13, 2026, EWTX trades at $41.26 with a market cap of $4.89B and a P/E ratio of -25.54. EWTX moved -9.16% today. Year to date, EWTX is +68.17%; over the trailing twelve months it is +198.19%. Its 52-week range spans $10.60 to $48.40. Analyst consensus is strong buy with an average price target of $50.60. Rallies surfaces EWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for EWTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $41.26 |
| Market Cap | $4.89B |
| P/E Ratio | -25.54 |
| EPS | $-1.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $48.40 |
| 52-Week Low | $10.60 |
| Volume | 873.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-167.79M |
| Gross Margin | 0.00% |
12 analysts cover EWTX: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.60.